meglumine has been researched along with Plasmacytoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grabner, G; Hoeftberger, R; Knosp, E; Noebauer-Huhmann, IM; Pinker, K; Stadlbauer, A; Stavrou, I; Szomolanyi, P; Trattnig, S; Weber, M | 1 |
1 other study(ies) available for meglumine and Plasmacytoma
Article | Year |
---|---|
High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Efficiency; Ependymoma; Female; Glioblastoma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Oligodendroglioma; Organometallic Compounds; Plasmacytoma; Sensitivity and Specificity | 2008 |